Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen-Reference-Cited by-同舟云学术

Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen

Published:2006-08 Issue:8 Volume:17 Page:1205-1212
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Martín M.,Lluch A.,Seguí M.A.,Ruiz A.,Ramos M.,Adrover E.,Rodríguez-Lescure Á.,Grosse R.,Calvo L.,Fernandez-Chacón C.,Roset M.,Antón A.,Isla D.,del Prado P. Martínez,Iglesias L.,Zaluski J.,Arcusa A.,López-Vega J.M.,Muñoz M.,Mel J.R.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/8/1205/418085/mdl135.pdf

Reference20 articles.

1. Polychemotherapy for early breast cancer: an overview of the randomised trials;Early Breast Cancer Trialists' Collaborative Group;Lancet,1998

2. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Early Breast Cancer Trialists' Collaborative Group;Lancet,2005

3. Adjuvant docetaxel for node-positive breast cancer;Martin;N Engl J Med,2005

4. TAC—A new standard in adjuvant therapy for breast cancer?;Perez;N Engl J Med,2005

5. Meeting highlights: International consensus panel on the treatment of primary breast cancer;Goldhirsch;J Natl Cancer Inst,1998

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Low BMI and Nutritional Status on Quality of Life and Disease Outcome in Breast Cancer Patients: Insights From a Tertiary Cancer Center in India;Nutrition and Cancer;2024-06-05

2. Evaluating the impact of training on therapeutic radiographer awareness of the signs and symptoms of neutropenic sepsis in patients undergoing concurrent chemoradiotherapy;Radiography;2024-03

3. Tumor-specific release of copper-incorporated diethyldithiocarbamate from an optimized apoferritin scaffold enables both potent and safe anti-cancer therapy;Chemical Engineering Journal;2023-10

4. Patient‐reported outcomes in older breast cancer survivors with and without prior chemotherapy treatment;Cancer Medicine;2023-08-08

5. Dysgeusia in Patients with Breast Cancer Treated with Chemotherapy—A Narrative Review;Nutrients;2023-01-01